早期目标导向镇静在急性脑损伤患者中的临床研究
该研究纳入2015年1月至2019年3月中国人民解放军总医院第三医学中心ICU收治的110例急性脑损伤患者,按随机数字表分为EGDS组和标准镇静组(STD组)。EGDS组持续静脉输注右美托咪定(初始剂量0.2 μg×kg-1×min-1)72小时,STD组根据临床情况静脉推注丙泊酚,两组均给予舒芬太尼镇痛。最终105例纳入分析(EGDS组56例,STD组49例)。结果显示EGDS组72小时GCS评分和BIS值高于STD组,机械通气时间更短,舒芬太尼总用量更少,但心动过缓发生率升高;作者认为EGDS安全可行,有助于改善急性脑损伤患者的神经功能。
要点
- EGDS组72小时GCS评分8.62±3.34 vs STD组7.89±2.74,BIS值60.87±24.79 vs 56.68±33.43,均P<0.05。
- EGDS组机械通气时间20.56±9.03小时 vs STD组27.75±11.23小时,舒芬太尼总用量79.16±26.76 μg vs 102.46±35.48 μg,均P<0.05。
- EGDS组心动过缓发生率10.71%(6/56) vs STD组6.12%(3/49),P<0.05;心动过速发生率14.29%(8/56) vs 38.78%(19/49),P<0.05。
- EGDS组72小时PaCO2 40.30±5.98 mmHg vs STD组31.57±8.20 mmHg,MAP 85.01±8.26 mmHg vs 89.54±9.41 mmHg,均P<0.05。
- EGDS组24小时氧合指数261.05±118.45 mmHg vs STD组226.45±96.54 mmHg,P<0.05;两组低血压发生率无显著差异。
适用人群与场景
- 2015年1月至2019年3月中国人民解放军总医院第三医学中心ICU收治的急性脑损伤患者,共110例随机分组,最终105例纳入分析(EGDS组56例,STD组49例)。
- 排除标准包括:因脑出血接受二次手术、脑疝加重、研究过程中退出或家属放弃治疗的患者。
诊断标准与关键阈值
- 采用RASS和脑电图双频指数(BIS)持续监测镇静深度。
处置流程与药物剂量
- EGDS组:持续静脉输注右美托咪定,初始剂量0.2 μg×kg-1×min-1,连续72小时。
- STD组:根据临床情况静脉推注丙泊酚。
- 两组均给予舒芬太尼镇痛,并根据病情给予甘露醇脱水降颅内压、止血或抗血小板等常规治疗。
研究设计与关键结果
- 研究类型为随机对照试验,单中心,最终纳入105例急性脑损伤患者(EGDS组56例,STD组49例),两组基线性别、年龄、脑损伤类型、APACHE II评分、GCS评分及机械通气率无显著差异。
- EGDS组72小时心率70.49±7.53 bpm vs STD组79.83±9.48 bpm,P<0.05。
- EGDS组72小时PaCO2 40.30±5.98 mmHg vs STD组31.57±8.20 mmHg,MAP 85.01±8.26 mmHg vs 89.54±9.41 mmHg,GCS评分8.62±3.34 vs 7.89±2.74,BIS值60.87±24.79 vs 56.68±33.43,均P<0.05。
- EGDS组72小时APACHE II评分17.10±7.05 vs STD组18.90±3.32,P>0.05。
- EGDS组24小时氧合指数261.05±118.45 mmHg vs STD组226.45±96.54 mmHg,P<0.05。
- EGDS组机械通气时间20.56±9.03小时 vs STD组27.75±11.23小时,舒芬太尼总用量79.16±26.76 μg vs 102.46±35.48 μg,均P<0.05。
- EGDS组心动过缓发生率10.71%(6/56) vs STD组6.12%(3/49),P<0.05;心动过速发生率14.29%(8/56) vs 38.78%(19/49),P<0.05;低血压发生率5.36%(3/56) vs 4.08%(2/49),P>0.05;STD组意外拔管发生率4.08%(2/49),EGDS组未发生。
证据类型、等级与局限
- 证据类型:随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对急性脑损伤患者,作者认为EGDS安全可行,有助于改善神经功能,可改善GCS评分和BIS值。
- 实施EGDS时需监测心动过缓的发生。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the value and feasibility of early goal directed sedation (EGDS) in patients with acute brain injury.
METHODS: A total of 110 patients with acute brain injury who were admitted to intensive care unit (ICU) of the Third Medical Center of the Chinese People's Liberation Army General Hospital from January 2015 to March 2019 were included and randomly divided into EGDS group and standard sedation group (STD) using the random number table. Patients in the EGDS group were sedated by continuous intravenous infusion of dexmedetomidine (initial dose of 0.2 μg×kg-1×min-1) for 72 consecutive hours. Patients in the STD group received intravenous bolus of propofol as appropriate clinically. Richmond agitation-sedation score (RASS) and electroencephalogram bispectral index (BIS) were used to continuously monitor the level of sedation. All patients were given sufentanil for analgesia. Routine treatments such as dehydration and reduction of intracranial pressure with mannitol, hemostasis or antiplatelet therapy were given according to the patients' condition. Vital signs, acute physiology and chronic health evaluation II (APACHE II) score, Glasgow coma scale (GCS) score, BIS value, artery blood gas analysis, duration of mechanical ventilation, analgesic dosage and adverse events were recorded in two groups before and 24, 48, and 72 hours after sedation.
RESULTS: (1) Among the 110 patients, patients who received the second surgery due to cerebral hemorrhage, had worsening of cerebral hernia, withdrew during the course of the study, or whose family members abandoned treatment were excluded from the study. Finally, 105 patients were enrolled in the study, including 56 patients in the EGDS group and 49 in the STD group. There was no significant difference in gender, age, types of brain injury, baseline APACHE II or GCS score or rate of mechanical ventilation between the two groups. (2) Compared with before sedation, heart rate (HR) significantly decreased till 72 hours after sedation in both groups, and the decrease in the EGDS groups was more obvious as compared with the STD group (bpm: 70.49±7.53 vs. 79.83±9.48, P < 0.05). Besides HR, significant improvement was found in the APACHE II and GCS scores in the STD group at 72 hours of sedation as compared with before sedation, and no significant difference was found in other indicators. Compared with before sedation, arterial partial pressure of carbon dioxide (PaCO2) was significantly increased from the 24th hour of sedation, mean artery pressure (MAP) was decreased significantly and GCS score, BIS value were increased significantly from the 48th hour of sedation, till 72 hours, which were all improved significantly as compared with the STD group [72-hour PaCO2 (mmHg, 1 mmHg = 0.133 kPa): 40.30±5.98 vs. 31.57±8.20, 72-hour MAP (mmHg): 85.01±8.26 vs. 89.54±9.41, 72-hour GCS score: 8.62±3.34 vs. 7.89±2.74, 72-hour BIS: 60.87±24.79 vs. 56.68±33.43, all P < 0.05]. APACHE II score was significantly lower only at the 72nd hour of sedation as compared with before sedation in the EGDS group, and no significant difference was found as compared with the STD group (17.10±7.05 vs. 18.90±3.32, P > 0.05). Oxygenation index (PaO2/FiO2) was significantly increased only at the 24th hour of sedation in the EGDS group as compared with the STD group (mmHg: 261.05±118.45 vs. 226.45±96.54, P < 0.05). (3) The duration of mechanical ventilation was significantly shorter in the EGDS group than that in the STD group (hours: 20.56±9.03 vs. 27.75±11.23, P < 0.05), and the total administered dose of sufentanil was significantly lower in the EGDS group than that in the STD group (μg: 79.16±26.76 vs. 102.46±35.48, P < 0.05). (4) Compared with the STD group, the incidence of bradycardia in the EGDS group was increased significantly [10.71% (6/56) vs. 6.12% (3/49), P < 0.05], while the incidence of tachycardia was decreased significantly [14.29% (8/56) vs. 38.78% (19/49), P < 0.05], but no significant difference was found in the incidence of hypotension [5.36% (3/56) vs. 4.08% (2/49), P > 0.05]. The incidence of unexpected extubation in the STD group was 4.08% (2/49), which did not occurre in the EGDS group.
CONCLUSIONS: EGDS can improve the GCS score and BIS value of patients with acute brain injury, suggesting that the EGDS is safe and feasible, which can help improve neurological function in patients with acute brain injury.
参考来源
- Yang G, Guo X, Mao G, et al. [Clinical research of early goal directed sedation applying in acute brain injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32386001. doi:10.3760/cma.j.cn121430-20200106-00092
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。